{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:06:08Z","timestamp":1789679168544,"version":"4.0.1"},"reference-count":306,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"am","delay-in-days":653,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021112","name":"Utkal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002742","name":"Banaras Hindu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021847","name":"Centro Svizzero di Calcolo Scientifico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Research"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.envres.2023.116573","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T05:32:54Z","timestamp":1689399174000},"page":"116573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics"],"prefix":"10.1016","volume":"235","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1516-5161","authenticated-orcid":false,"given":"Vinayak","family":"Nayak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7942-9621","authenticated-orcid":false,"given":"Sushmita","family":"Patra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kshitij RB","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bristy","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Das Nishant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh Kumar","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3793-0450","authenticated-orcid":false,"given":"Jay","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanatan","family":"Majhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3682-3573","authenticated-orcid":false,"given":"Rohit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam S.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6790-4261","authenticated-orcid":false,"given":"Ravindra Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2943-3681","authenticated-orcid":false,"given":"Rout George","family":"Kerry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.envres.2023.116573_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33434-7","article-title":"Photo-catalytic killing of HeLa cancer cells using facile synthesized pure and Ag loaded WO3 nanoparticles","volume":"8","author":"AbuMousa","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib2","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1038\/s41598-023-34638-2","article-title":"Proof of concept nanotechnological approach to in vitro targeting of malignant melanoma for enhanced immune checkpoint inhibition","volume":"13","author":"Alharbi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib3","doi-asserted-by":"crossref","first-page":"8837","DOI":"10.1038\/s41598-021-88164-0","article-title":"Zinc oxide nanoparticles using plant Lawsonia inermis and their mosquitocidal, antimicrobial, anticancer applications showing moderate side effects","volume":"11","author":"Amuthavalli","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1186\/s12885-019-6131-1","article-title":"CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing","volume":"19","author":"Andersch","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.envres.2023.116573_bib5","doi-asserted-by":"crossref","first-page":"16028","DOI":"10.1073\/pnas.0407218101","article-title":"A polymer library approach to suicide gene therapy for cancer","volume":"101","author":"Anderson","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.envres.2023.116573_bib6","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2022-0079","article-title":"The use of adenoviral vectors in gene therapy and vaccine approaches","volume":"45","author":"Ara\u00fajo","year":"2022","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.envres.2023.116573_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101532","article-title":"Nanotechnological approaches in prostate cancer therapy: integration of engineering and biology","volume":"45","author":"Ashrafizadeh","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.envres.2023.116573_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10353","article-title":"Nano)platforms in bladder cancer therapy: challenges and opportunities","volume":"8","author":"Ashrafizadeh","year":"2023","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.envres.2023.116573_bib9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/jcp.29044","article-title":"Cancer stem cells: a review from origin to therapeutic implications","volume":"235","author":"Atashzar","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.envres.2023.116573_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/srep35376","article-title":"Massive release of extracellular vesicles from cancer cells after photodynamic treatment or chemotherapy","volume":"6","author":"Aubertin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12929-018-0426-4","article-title":"Cancer stem cells as key drivers of tumour progression","volume":"25","author":"Ayob","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.envres.2023.116573_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12985-023-02048-5","article-title":"Potential of CRISPR\/Cas system as emerging tools in the detection of viral hepatitis infection","volume":"20","author":"Bahrulolum","year":"2023","journal-title":"Virol. J."},{"key":"10.1016\/j.envres.2023.116573_bib13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41467-021-21071-0","article-title":"Cyclodextrin-based host-guest complexes loaded with regorafenib for colorectal cancer treatment","volume":"12","author":"Bai","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envres.2023.116573_bib14","series-title":"Mass Spectrometry-Based Extracellular Vesicle Micromolecule Detection in Cancer Biomarker Discovery: an Overview of Metabolomics and Lipidomics","author":"Bai","year":"2023"},{"key":"10.1016\/j.envres.2023.116573_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111775","article-title":"Lipid nanocapsules co-encapsulating paclitaxel and salinomycin for eradicating breast cancer and cancer stem cells","volume":"204","author":"Basu","year":"2021","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.envres.2023.116573_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48959-8","article-title":"Copper oxide nanoparticles inhibit pancreatic tumor growth primarily by targeting tumor initiating cells","volume":"9","author":"Benguigui","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib17","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1038\/s41598-021-88482-3","article-title":"Protein-olive oil-in-water nanoemulsions as encapsulation materials for curcumin acting as anticancer agent towards MDA-MB-231 cells","volume":"11","author":"Bharmoria","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.103961","article-title":"A critical review on the dissemination of PH and stimuli-responsive polymeric nanoparticular systems to improve drug delivery in cancer therapy","volume":"185","author":"Bhattacharya","year":"2023","journal-title":"Crit. Rev. Oncol.-Hematol."},{"key":"10.1016\/j.envres.2023.116573_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1172\/JCI28803","article-title":"The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer","volume":"117","author":"Bosco","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.envres.2023.116573_bib20","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/jpm11111211","article-title":"Trop-2 therapy in metastatic triple-negative breast cancer in Italy: clinical opportunity and regulatory pitfalls","volume":"11","author":"Bravaccini","year":"2021","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.envres.2023.116573_bib21","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.celrep.2019.10.039","article-title":"The axonal membrane protein PRG2 inhibits PTEN and directs growth to branches","volume":"29","author":"Brosig","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.envres.2023.116573_bib22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3389\/fimmu.2019.00771","article-title":"Myeloid derived suppressor cells interactions with natural killer cells and pro-angiogenic activities: roles in tumor progression","volume":"10","author":"Bruno","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.envres.2023.116573_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.envres.2023.116573_bib24","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.3390\/cancers13133324","article-title":"Extracellular vesicles as mediators of cancer disease and as nanosystems in theranostic applications","volume":"13","author":"Burgos-Ravanal","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.envres.2023.116573_bib25","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/genes13081370","article-title":"Appraisal for the potential of viral and nonviral vectors in gene therapy: a review","volume":"13","author":"Butt","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.envres.2023.116573_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00109-020-01874-2","article-title":"Clinical implications of intratumor heterogeneity: challenges and opportunities","volume":"98","author":"Cajal","year":"2020","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.envres.2023.116573_bib27","series-title":"Cancer Today, International Agency for Research on Cancer (IARC)","year":"2020"},{"key":"10.1016\/j.envres.2023.116573_bib28","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.3390\/cancers13122929","article-title":"Biparatopic protein nanoparticles for the precision therapy of cxcr4+ cancers","volume":"13","author":"Cano-Garrido","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.envres.2023.116573_bib29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fonc.2014.00252","article-title":"The PTEN\/PI3K\/AKT pathway in vivo, cancer mouse models","volume":"4","author":"Carnero","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.envres.2023.116573_bib30","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1038\/onc.2008.247","article-title":"The PTEN-PI3K pathway: of feedbacks and cross-talks","volume":"27","author":"Carracedo","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.envres.2023.116573_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109213","article-title":"Protospacer adjacent motif (PAM)-distal sequences engage CRISPR Cas9 DNA target cleavage","volume":"9","author":"Cencic","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.envres.2023.116573_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/biomedicines11010109","article-title":"Targeting PI3K\/AKT\/mTOR pathway in breast cancer: from biology to clinical challenges","volume":"11","author":"Cerma","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.envres.2023.116573_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1899469","article-title":"Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine","volume":"10","author":"Cha","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.envres.2023.116573_bib34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41392-021-00706-0","article-title":"Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells","volume":"6","author":"Charo","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.envres.2023.116573_bib35","doi-asserted-by":"crossref","DOI":"10.1101\/2023.05.18.541287","article-title":"GPX4-VIM equates a proliferating DTP state in TNBC subtypes with converged vulnerabilities to autophagy and glutathione inhibition (preprint)","author":"Chaudhary","year":"2023","journal-title":"Cancer Biology"},{"key":"10.1016\/j.envres.2023.116573_bib36","article-title":"Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells","volume":"6","author":"Chen","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.envres.2023.116573_bib37","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3892\/or.2017.5697","article-title":"Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization","volume":"38","author":"Chen","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/biomedicines9020151","article-title":"Bacterial genotoxin-coated nanoparticles for radiotherapy sensitization in prostate cancer","volume":"9","author":"Chen","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.envres.2023.116573_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.smim.2018.01.002","article-title":"Mesenchymal-myeloid interaction in the regulation of immunity","volume":"35","author":"Cheung","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.envres.2023.116573_bib40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41467-017-00530-7","article-title":"Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2\/CD39L1 in hepatocellular carcinoma","volume":"8","author":"Chiu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envres.2023.116573_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.pacs.2023.100500","article-title":"pH-responsive ratiometric photoacoustic imaging of polyaniline nanoparticle-coated needle for targeted cancer biopsy","volume":"31","author":"Choe","year":"2023","journal-title":"Photoacoustics"},{"key":"10.1016\/j.envres.2023.116573_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe7378","article-title":"SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma","volume":"13","author":"Choe","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.envres.2023.116573_bib43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","article-title":"Targeting signalling pathways and the immune microenvironment of cancer stem cells \u2014 a clinical update","volume":"17","author":"Clara","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.envres.2023.116573_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100762","article-title":"Targeted nanomedicine modalities for prostate cancer treatment","volume":"56","author":"Cohen","year":"2021","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.envres.2023.116573_bib45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.envres.2023.116573_bib46","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.celrep.2015.02.059","article-title":"Direct involvement of retinoblastoma family proteins in DNA repair by non-homologous end-joining","volume":"10","author":"Cook","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.envres.2023.116573_bib47","article-title":"Mutational analysis of oncogenic AKT1 gene associated with breast cancer risk in the high altitude Ecuadorian mestizo population","author":"Cort\u00e9s","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.envres.2023.116573_bib48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10549-018-4697-y","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in triple-negative breast cancer: a review","volume":"169","author":"Costa","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.envres.2023.116573_bib49","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1101\/gad.1399906","article-title":"HIF-2\u03b1 regulates Oct-4: effects of hypoxiaon stem cell function, embryonic development, and tumor growth","volume":"20","author":"Covello","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.envres.2023.116573_bib50","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1038\/s41467-018-05843-9","article-title":"Cas9 immunity creates challenges for CRISPR gene editing therapies","volume":"9","author":"Crudele","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envres.2023.116573_bib51","series-title":"Cube Biotech, the Flag\u00ae-Tag \u2013 the Definition of a High Affinity Protein Tag [WWW Document]","year":"2022"},{"key":"10.1016\/j.envres.2023.116573_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13046-019-1233-9","article-title":"Hypoxia-inducible gene 2 promotes the immune escape of hepatocellular carcinoma from nature killer cells through the interleukin-10-STAT3 signaling pathway","volume":"38","author":"Cui","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.envres.2023.116573_bib53","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1093\/nar\/gkg405","article-title":"DNA binding properties of the adenovirus DNA replication priming protein pTP","volume":"31","author":"de Jong","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.envres.2023.116573_bib54","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.envres.2023.116573_bib55","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.apsb.2022.12.003","article-title":"Self-assembled multifunctional nanotheranostics against circulating tumor clusters in metastatic breast cancer","volume":"13","author":"Dhandapani","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.envres.2023.116573_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.588306","article-title":"Aptamer-driven toxin gene delivery in U87 model glioblastoma cells","volume":"12","author":"di Leandro","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.envres.2023.116573_bib57","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-023-01362-3","article-title":"Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy","author":"Dogbey","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.envres.2023.116573_bib58","doi-asserted-by":"crossref","first-page":"E2972","DOI":"10.3390\/cancers12102972","article-title":"Therapeutic potential of PI3K\/AKT\/mTOR pathway in gastrointestinal stromal tumors: rationale and progress","volume":"12","author":"Duan","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.envres.2023.116573_bib59","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1101\/gad.282145.116","article-title":"RB1: a prototype tumor suppressor and an enigma","volume":"30","author":"Dyson","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.envres.2023.116573_bib60","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.3390\/cells9081896","article-title":"Advances in therapeutic targeting of cancer stem cells within the tumor microenvironment: an updated review","volume":"9","author":"Dzobo","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.envres.2023.116573_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.micromeso.2019.06.002","article-title":"Multifunctional curcumin-loaded mesoporous silica nanoparticles for cancer chemoprevention and therapy","volume":"291","author":"Elbialy","year":"2020","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.envres.2023.116573_bib62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41419-020-03308-w","article-title":"A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature","volume":"12","author":"El-Sahli","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.envres.2023.116573_bib63","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12935-020-01719-5","article-title":"The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment","volume":"21","author":"Emami Nejad","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.envres.2023.116573_bib64","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5483\/BMBRep.2017.50.3.222","article-title":"Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting","volume":"50","author":"Eun","year":"2017","journal-title":"BMB Rep."},{"key":"10.1016\/j.envres.2023.116573_bib65","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ajh.25418","article-title":"An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer","volume":"94","author":"Feins","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.envres.2023.116573_bib66","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.trecan.2020.12.014","article-title":"The role of the microenvironment and immune system in regulating stem cell fate in cancer","volume":"7","author":"Ferguson","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.envres.2023.116573_bib67","series-title":"Adenoviral Vectors for Gene Therapy","first-page":"139","article-title":"6 - upstream bioprocess for adenovirus vectors","author":"Fernandes","year":"2016"},{"key":"10.1016\/j.envres.2023.116573_bib68","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrm827","article-title":"Adenovirus-5 E1A: paradox and paradigm","volume":"3","author":"Frisch","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.envres.2023.116573_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.644737","article-title":"PIK3CA mutations as a molecular target for hormone receptor-positive, HER2-negative metastatic breast cancer","volume":"11","author":"Fusco","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.envres.2023.116573_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.663949","article-title":"CRISPR-based COVID-19 testing: toward next-generation point-of-care diagnostics","volume":"11","author":"Ganbaatar","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.envres.2023.116573_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103469","article-title":"Mitochondrial-targeted nanoparticles: delivery and therapeutic agents in cancer","volume":"28","author":"Ganji","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.envres.2023.116573_bib72","article-title":"Vesicular stomatitis virus (VSV) G glycoprotein can be modified to create a Her2\/neu-targeted VSV that eliminates large implanted mammary tumors","author":"Gao","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.envres.2023.116573_bib73","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3389\/fimmu.2020.01109","article-title":"CAR-T cells hit the tumor microenvironment: strategies to overcome tumor escape","volume":"11","author":"Garcia","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.envres.2023.116573_bib74","doi-asserted-by":"crossref","first-page":"E2579","DOI":"10.1073\/pnas.1208507109","article-title":"Cas9\u2013crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria","volume":"109","author":"Gasiunas","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.envres.2023.116573_bib75","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccr.2007.10.017","article-title":"Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors","volume":"12","author":"Gauthier","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.envres.2023.116573_bib76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1535676019899502","article-title":"Viral vector systems for gene therapy: a comprehensive literature review of progress and biosafety challenges","volume":"25","author":"Ghosh","year":"2020","journal-title":"Appl. Biosaf."},{"key":"10.1016\/j.envres.2023.116573_bib77","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jconrel.2012.04.008","article-title":"Virus-mediated gene delivery for human gene therapy","volume":"161","author":"Giacca","year":"2012","journal-title":"J Control Release, Drug Delivery Research in Europe"},{"key":"10.1016\/j.envres.2023.116573_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2019.110952","article-title":"Influence of synthesis methods on the internalization of fluorescent gold nanoparticles into glioblastoma stem-like cells","volume":"203","author":"Giesen","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.envres.2023.116573_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213275","article-title":"Engineering dual-stimuli responsive poly(vinyl alcohol) nanofibrous membranes for cancer treatment by magnetic hyperthermia","volume":"145","author":"Gon\u00e7alves","year":"2023","journal-title":"Biomater Adv."},{"key":"10.1016\/j.envres.2023.116573_bib80","doi-asserted-by":"crossref","first-page":"11899","DOI":"10.1021\/acs.analchem.1c02533","article-title":"CRISPR\/Cas-based in vitro diagnostic platforms for cancer biomarker detection","volume":"93","author":"Gong","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.envres.2023.116573_bib81","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/NEN.0000000000000093","article-title":"PTEN mutations and activation of the PI3K\/Akt\/mTOR signaling pathway in papillary tumors of the pineal region","volume":"73","author":"Goschzik","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.envres.2023.116573_bib82","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1038\/s41467-020-19225-7","article-title":"Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy","volume":"11","author":"Gregory","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envres.2023.116573_bib83","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1038\/s41388-018-0261-9","article-title":"Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a\/Rora and miR-21\/Pten Pathways","volume":"37","author":"Guo","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.envres.2023.116573_bib84","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1002\/ijc.32052","article-title":"Glioma exosomes mediate the expansion and function of myeloid-derived suppressor cells through microRNA-29a\/Hbp1 and microRNA-92a\/Prkar1a pathways","volume":"144","author":"Guo","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.envres.2023.116573_bib85","doi-asserted-by":"crossref","first-page":"80521","DOI":"10.18632\/oncotarget.11825","article-title":"Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR","volume":"7","author":"Guo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.envres.2023.116573_bib86","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.2215\/CJN.06620714","article-title":"T cells: soldiers and spies\u2014the surveillance and control of effector T cells by regulatory T cells","volume":"10","author":"Hall","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.envres.2023.116573_bib87","article-title":"CAR-engineered NK cells targeting wild-type EGFR and EGFRvIII enhance killing of glioblastoma and patient-derived glioblastoma stem cells","volume":"5","author":"Han","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib88","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/annonc\/mdu247","article-title":"Activated PI3K\/AKT and MAPK pathways are potential good prognostic markers in node-positive, triple-negative breast cancer","volume":"25","author":"Hashimoto","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.envres.2023.116573_bib89","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.4049\/jimmunol.1302140","article-title":"Cutting edge: hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-\u03b21","volume":"191","author":"Hasmim","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.envres.2023.116573_bib90","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/pr9010045","article-title":"Cancer stem cell microenvironment models with biomaterial scaffolds in vitro","volume":"9","author":"Hassan","year":"2021","journal-title":"Processes"},{"key":"10.1016\/j.envres.2023.116573_bib91","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.molcel.2007.08.023","article-title":"Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture","volume":"28","author":"Hassler","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.envres.2023.116573_bib92","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.2147\/OTT.S260391","article-title":"A concise review: the role of stem cells in cancer progression and therapy","volume":"14","author":"Hayat","year":"2021","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.envres.2023.116573_bib93","article-title":"An in vitro model of tumor heterogeneity resolves genetic, epigenetic, and stochastic sources of cell state variability","volume":"19","author":"Hayford","year":"2021","journal-title":"pbio"},{"key":"10.1016\/j.envres.2023.116573_bib94","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.envres.2023.116573_bib95","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.3390\/ijms23084153","article-title":"Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology","volume":"23","author":"Hersh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.envres.2023.116573_bib96","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12033-022-00567-0","article-title":"A review on the mechanism and applications of CRISPR\/Cas9\/Cas12\/Cas13\/Cas14 proteins utilized for genome engineering","volume":"65","author":"Hillary","year":"2023","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.envres.2023.116573_bib97","doi-asserted-by":"crossref","first-page":"eabg3217","DOI":"10.1126\/sciadv.abg3217","article-title":"Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy","volume":"7","author":"Ho","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.envres.2023.116573_bib98","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccell.2020.07.005","article-title":"Engineering CAR-T cells for next-generation cancer therapy","volume":"38","author":"Hong","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.envres.2023.116573_bib99","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb0020","article-title":"Vascular disrupting agent induced aggregation of gold nanoparticles for photothermally enhanced tumor vascular disruption","volume":"6","author":"Hong","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.envres.2023.116573_bib100","article-title":"Theranostic polymeric nanoparticles as a new approach in cancer therapy and diagnosis: a review","volume":"29","author":"Hosseini","year":"2023","journal-title":"Mater. Today Chem."},{"key":"10.1016\/j.envres.2023.116573_bib101","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: an overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.envres.2023.116573_bib102","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.envres.2023.116573_bib103","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ymthe.2017.11.016","article-title":"Hypoxic lung-cancer-derived extracellular vesicle MicroRNA-103a increases the oncogenic effects of macrophages by targeting PTEN","volume":"26","author":"Hsu","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.envres.2023.116573_bib104","doi-asserted-by":"crossref","DOI":"10.21037\/atm-21-698","article-title":"PIK3CA mutation confers resistance to chemotherapy in triple-negative breast cancer by inhibiting apoptosis and activating the PI3K\/AKT\/mTOR signaling pathway","volume":"9","author":"Hu","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.envres.2023.116573_bib105","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.1007\/s00253-020-10802-w","article-title":"The limiting factors of oncolytic virus immunotherapy and the approaches to overcome them","volume":"104","author":"Hu","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.envres.2023.116573_bib106","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1038\/s41598-020-59736-3","article-title":"Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer","volume":"10","author":"Hu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib107","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.omto.2020.04.008","article-title":"LunX-CAR T cells as a targeted therapy for non-small cell lung cancer","volume":"17","author":"Hu","year":"2020","journal-title":"Mol. Ther.--Oncolytics"},{"key":"10.1016\/j.envres.2023.116573_bib108","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13045-021-01137-8","article-title":"Targeting Akt in cancer for precision therapy","volume":"14","author":"Hua","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.envres.2023.116573_bib109","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fphar.2018.00790","article-title":"Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization","volume":"9","author":"Hua","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.envres.2023.116573_bib110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.trecan.2018.05.006","article-title":"Applications of CRISPR-Cas enzymes in cancer therapeutics and detection","volume":"4","author":"Huang","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.envres.2023.116573_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-020-0150-x","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.envres.2023.116573_bib112","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf2400","article-title":"Immune cell shuttle for precise delivery of nanotherapeutics for heart disease and cancer","volume":"7","author":"Huang","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.envres.2023.116573_bib113","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/s41467-021-22618-x","article-title":"FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envres.2023.116573_bib114","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd8836","article-title":"SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models","author":"Hyrenius-Wittsten","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.envres.2023.116573_bib115","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3390\/cancers15041307","article-title":"Extracellular vesicles in liquid biopsies as biomarkers for solid tumors","volume":"15","author":"Irmer","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.envres.2023.116573_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2022.136020","article-title":"Multifaceted role of polyphenols in the treatment and management of neurodegenerative diseases","volume":"307","author":"Islam","year":"2022","journal-title":"Chemosphere"},{"key":"10.1016\/j.envres.2023.116573_bib117","article-title":"Nanoparticle-mediated polycaprolactone based nanofiber mats for enhanced apoptosis of breast cancer cell line with improved cell viability of fibroblast cell line: controlled drug release and antimicrobial assay","volume":"84","author":"Jaisankar","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.envres.2023.116573_bib118","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s13238-020-00708-8","article-title":"The expanded development and application of CRISPR system for sensitive nucleotide detection","volume":"11","author":"Jia","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.envres.2023.116573_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00690","article-title":"Anti-GPC3-CAR T cells suppress the growth of tumor cells in patient-derived xenografts of hepatocellular carcinoma","volume":"7","author":"Jiang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.envres.2023.116573_bib120","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1172\/JCI81568","article-title":"RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation","volume":"126","author":"Jones","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.envres.2023.116573_bib121","series-title":"Oncogenic Viruses","first-page":"81","article-title":"Chapter 5 - oncoviruses: future prospects of molecular mechanisms and therapeutic strategies","author":"Kalarani","year":"2023"},{"key":"10.1016\/j.envres.2023.116573_bib122","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","article-title":"The role of extracellular vesicles in cancer","volume":"186","author":"Kalluri","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.envres.2023.116573_bib123","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/cancers12020472","article-title":"Effect of diphtheria toxin-based gene therapy for hepatocellular carcinoma","volume":"12","author":"Kamimura","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.envres.2023.116573_bib124","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41551-021-00760-7","article-title":"CRISPR-based diagnostics","volume":"5","author":"Kaminski","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.envres.2023.116573_bib125","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bjc.6602970","article-title":"Mutation of the PIK3CA oncogene in human cancers","volume":"94","author":"Karakas","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.envres.2023.116573_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154010","article-title":"PI3K\/Akt\/mTOR signaling pathway in cancer stem cells","volume":"237","author":"Karami fath","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.envres.2023.116573_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.115338","article-title":"State-of-art advances on removal, degradation and electrochemical monitoring of 4-aminophenol pollutants in real samples: a review","volume":"222","author":"Karimi-Maleh","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.envres.2023.116573_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2023.138815","article-title":"Calf thymus ds-DNA intercalation with pendimethalin herbicide at the surface of ZIF-8\/Co\/rGO\/C3N4\/ds-DNA\/SPCE; A bio-sensing approach for pendimethalin quantification confirmed by molecular docking study","volume":"332","author":"Karimi-Maleh","year":"2023","journal-title":"Chemosphere"},{"key":"10.1016\/j.envres.2023.116573_bib129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.addr.2015.05.009","article-title":"Progress and problems with the use of suicide genes for targeted cancer therapy","volume":"99","author":"Karjoo","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.envres.2023.116573_bib130","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4161\/rna.24203","article-title":"crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus","volume":"10","author":"Karvelis","year":"2013","journal-title":"RNA Biol."},{"key":"10.1016\/j.envres.2023.116573_bib131","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11154-020-09606-0","article-title":"Molecular prospect of type-2 diabetes: nanotechnology based diagnostics and therapeutic intervention","volume":"22","author":"Kerry","year":"2021","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.envres.2023.116573_bib132","doi-asserted-by":"crossref","first-page":"90948","DOI":"10.18632\/oncotarget.18770","article-title":"PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.envres.2023.116573_bib133","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3390\/biom11081162","article-title":"CRISPR as a diagnostic tool","volume":"11","author":"Kim","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.envres.2023.116573_bib134","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/14712598.2021.1843628","article-title":"Mesothelin-targeted CAR-T cell therapy for solid tumors","volume":"21","author":"Klampatsa","year":"2021","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.envres.2023.116573_bib135","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1038\/s41467-021-23244-3","article-title":"PLGA-particle vaccine carrying TLR3\/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy","volume":"12","author":"Koerner","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envres.2023.116573_bib136","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay1601","article-title":"Nanoparticle interactions with immune cells dominate tumor retention and induce T cell\u2013mediated tumor suppression in models of breast cancer","volume":"6","author":"Korangath","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.envres.2023.116573_bib137","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jcyt.2014.02.012","article-title":"T cells redirected to IL13R\u03b12 with IL13 mutein-CARs have antiglioma activity but also recognize IL13R\u03b11","volume":"16","author":"Krebs","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.envres.2023.116573_bib138","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41598-020-79631-1","article-title":"Preparation and characterization of nanocurcumin based hybrid virosomes as a drug delivery vehicle with enhanced anticancerous activity and reduced toxicity","volume":"11","author":"Kumar","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib139","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.650772","article-title":"The role of Notch, Hedgehog, and Wnt signaling pathways in the resistance of tumors to anticancer therapies","volume":"9","author":"Kumar","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.envres.2023.116573_bib140","article-title":"Improved delivery and antimetastatic effects of Stattic by self-assembled amphiphilic pendant-dendron copolymer micelles in breast cancer cell lines","volume":"59","author":"Kwa","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.envres.2023.116573_bib141","doi-asserted-by":"crossref","first-page":"24284","DOI":"10.18632\/oncotarget.8301","article-title":"The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells","volume":"7","author":"Labrecque","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.envres.2023.116573_bib142","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1021\/acsmedchemlett.9b00548","article-title":"Spotlight on AKT: current therapeutic challenges","volume":"11","author":"Landel","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.envres.2023.116573_bib143","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis."},{"key":"10.1016\/j.envres.2023.116573_bib144","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/36038","article-title":"Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7","volume":"391","author":"Lee","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.envres.2023.116573_bib145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12943-023-01741-x","article-title":"Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis","volume":"22","author":"Lee","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.envres.2023.116573_bib146","series-title":"Reference Module in Biomedical Sciences","article-title":"Adenoviruses: molecular biology","author":"Leppard","year":"2014"},{"key":"10.1016\/j.envres.2023.116573_bib147","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.omto.2022.02.015","article-title":"A novel PD-L1-targeted shark VNAR single-domain-based CAR-T cell strategy for treating breast cancer and liver cancer","volume":"24","author":"Li","year":"2022","journal-title":"Mol. Ther.--Oncolytics"},{"key":"10.1016\/j.envres.2023.116573_bib148","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.3390\/cancers13112724","article-title":"A novel off-the-Shelf trastuzumab-armed NK cell therapy (ACE1702) using antibody-cell-conjugation technology","volume":"13","author":"Li","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.envres.2023.116573_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-018-0028-z","article-title":"CRISPR-Cas12a-assisted nucleic acid detection","volume":"4","author":"Li","year":"2018","journal-title":"Cell Discov."},{"key":"10.1016\/j.envres.2023.116573_bib150","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.3390\/ijms24097736","article-title":"Viral vector-based gene therapy","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.envres.2023.116573_bib151","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4161\/cc.8.9.8255","article-title":"PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approaches","volume":"8","author":"Ligresti","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.envres.2023.116573_bib152","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.drudis.2019.02.011","article-title":"CRISPR\/Cas9: a powerful tool for identification of new targets for cancer treatment","volume":"24","author":"Liu","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.envres.2023.116573_bib153","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.envres.2023.116573_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.116177","article-title":"A strategy for As(III) determination based on ultrafine gold nanoparticles decorated on magnetic graphene oxide","volume":"231","author":"Liu","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.envres.2023.116573_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114619","article-title":"Strategies to overcome\/penetrate the BBB for systemic nanoparticle delivery to the brain\/brain tumor","volume":"191","author":"Liu","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.envres.2023.116573_bib156","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.envres.2023.116573_bib157","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/pcmedi\/pbab014","article-title":"Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics","volume":"4","author":"Liu","year":"2021","journal-title":"Precis. Clin. Med."},{"key":"10.1016\/j.envres.2023.116573_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115207","article-title":"Novel construction of multifunctional photo-responsive and nucleic acid-triggered doxorubicin-releasing liposomes for cancer therapy","volume":"250","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.envres.2023.116573_bib159","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1038\/s41467-022-31799-y","article-title":"Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma","volume":"13","author":"Lu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envres.2023.116573_bib160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2013.07.009","article-title":"Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells","volume":"340","author":"Lu","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.envres.2023.116573_bib161","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/v15030698","article-title":"Viral vectors in gene therapy: where do we stand in 2023","volume":"15","author":"Lundstrom","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.envres.2023.116573_bib162","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd7614","article-title":"Near-infrared light\u2013triggered platelet arsenal for combined photothermal-immunotherapy against cancer","volume":"7","author":"Lv","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.envres.2023.116573_bib163","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jcyt.2023.02.010","article-title":"Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays","volume":"25","author":"Ma","year":"2023","journal-title":"Cytotherapy"},{"key":"10.1016\/j.envres.2023.116573_bib164","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.trecan.2022.10.003","article-title":"The emerging field of oncolytic virus-based cancer immunotherapy","volume":"9","author":"Ma","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.envres.2023.116573_bib165","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1038\/s41467-020-18399-4","article-title":"Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy","volume":"11","author":"Ma","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envres.2023.116573_bib166","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41579-019-0299-x","article-title":"Evolutionary classification of CRISPR\u2013Cas systems: a burst of class 2 and derived variants","volume":"18","author":"Makarova","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.envres.2023.116573_bib167","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.envres.2023.116573_bib168","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/1078-0432.CCR-21-1565","article-title":"Relevance of pRB loss in human malignancies","volume":"28","author":"Mandigo","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.envres.2023.116573_bib169","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.envres.2023.116573_bib170","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3389\/fimmu.2019.01848","article-title":"Immune conversion of tumor microenvironment by oncolytic viruses: the protoparvovirus H-1PV case study","volume":"10","author":"Marchini","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.envres.2023.116573_bib171","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2217\/fvl-2016-0129","article-title":"Designing and building oncolytic viruses","volume":"12","author":"Maroun","year":"2017","journal-title":"Future Virol."},{"key":"10.1016\/j.envres.2023.116573_bib172","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/biomedicines6040105","article-title":"CRISPR\/Cas9 for cancer therapy: hopes and challenges","volume":"6","author":"Martinez-Lage","year":"2018","journal-title":"Biomedica"},{"key":"10.1016\/j.envres.2023.116573_bib173","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13058-020-01284-9","article-title":"Frequency and spectrum of PIK3CA somatic mutations in breast cancer","volume":"22","author":"Mart\u00ednez-S\u00e1ez","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.envres.2023.116573_bib174","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.662232","article-title":"AKTinhibitors: new weapons in the fight against breast cancer?","volume":"12","author":"Martorana","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.envres.2023.116573_bib175","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49978-1","article-title":"Destruction of tumor mass by gadolinium-loaded nanoparticles irradiated with monochromatic X-rays: implications for the Auger therapy","volume":"9","author":"Matsumoto","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib176","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.3390\/cimb45060307","article-title":"Adenovirus as a vector and oncolytic virus","volume":"45","author":"Matsunaga","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.envres.2023.116573_bib177","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fimmu.2017.00358","article-title":"Human melanoma-derived extracellular vesicles regulate dendritic cell maturation","volume":"8","author":"Maus","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.envres.2023.116573_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.832765","article-title":"Special chimeric antigen receptor (CAR) modifications of T cells: a review","volume":"12","author":"Miao","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.envres.2023.116573_bib179","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1389201019666180418095526","article-title":"CAR T-cell therapy: a new era in cancer immunotherapy","volume":"19","author":"Miliotou","year":"2018","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.envres.2023.116573_bib180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jconrel.2020.06.038","article-title":"In vivo gene delivery mediated by non-viral vectors for cancer therapy","volume":"325","author":"Mohammadinejad","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.envres.2023.116573_bib181","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.21873\/anticanres.12824","article-title":"Novel human NK cell line carrying CAR targeting EGFRvIII induces antitumor effects in glioblastoma cells","volume":"38","author":"Murakami","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.envres.2023.116573_bib182","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1038\/s41598-023-34870-w","article-title":"pH-responsive chitosan\/acrylamide\/gold\/nanocomposite supported with silver nanoparticles for controlled release of anticancer drug","volume":"13","author":"Nasef","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib183","article-title":"PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha","year":"2022","journal-title":"(Gene ID: 5290) [Homo sapiens (human)] - Gene - NCBI [WWW Document]"},{"key":"10.1016\/j.envres.2023.116573_bib184","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.onc.1200833","article-title":"Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein","volume":"14","author":"Nielsen","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.envres.2023.116573_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2023.04.043","article-title":"Biomaterials for chimeric antigen receptor T cell engineering","author":"Niu","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.envres.2023.116573_bib186","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1158\/0008-5472.CAN-12-1383","article-title":"Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells","volume":"72","author":"Noman","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.envres.2023.116573_bib187","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.4049\/jimmunol.0800854","article-title":"The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis","volume":"182","author":"Noman","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.envres.2023.116573_bib188","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejpb.2020.11.014","article-title":"Lipid-encapsulated upconversion nanoparticle for near-infrared light-mediated carbon monoxide release for cancer gas therapy","volume":"158","author":"Opoku-Damoah","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.envres.2023.116573_bib189","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/cancers12040879","article-title":"Revisiting cancer stem cells as the origin of cancer-associated cells in the tumor microenvironment: a hypothetical view from the potential of iPSCs","volume":"12","author":"Osman","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.envres.2023.116573_bib190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.advms.2022.12.002","article-title":"Monoisotopic silver nanoparticles-based mass spectrometry imaging of human bladder cancer tissue: biomarker discovery","volume":"68","author":"Ossoli\u0144ski","year":"2023","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.envres.2023.116573_bib191","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1080\/15476286.2019.1649585","article-title":"Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977\/miR-153 axis","volume":"16","author":"Ou","year":"2019","journal-title":"RNA Biol."},{"key":"10.1016\/j.envres.2023.116573_bib192","article-title":"Therapeutic and diagnostic relevance of CRISPR technology","volume":"138","author":"Ouar","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.envres.2023.116573_bib193","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/diagnostics12030656","article-title":"Cell signaling pathways that promote radioresistance of cancer cells","volume":"12","author":"Ouellette","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.envres.2023.116573_bib194","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3324\/haematol.2009.013797","article-title":"Role of the PI3K\/AKT and mTOR signaling pathways in acute myeloid leukemia","volume":"95","author":"Park","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.envres.2023.116573_bib195","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/nar\/26.5.1240","article-title":"Adenovirus DNA polymerase: domain organisation and interaction with preterminal protein","volume":"26","author":"Parker","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.envres.2023.116573_bib196","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/annonc\/mdz133","article-title":"Targeting the PI3-kinase pathway in triple-negative breast cancer","volume":"30","author":"Pascual","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.envres.2023.116573_bib197","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.colsurfb.2019.03.021","article-title":"Multi-targeted approach by 2-benzimidazolylquinoxalines-loaded cationic arginine liposomes against \u0441ervical cancer cells in vitro","volume":"178","author":"Pashirova","year":"2019","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.envres.2023.116573_bib198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-020-0160-4","article-title":"Retinoblastoma protein expression and its predictors in triple-negative breast cancer","volume":"6","author":"Patel","year":"2020","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.envres.2023.116573_bib199","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.033464","article-title":"Metabolic traits of cancer stem cells","volume":"11","author":"Peixoto","year":"2018","journal-title":"Dis. Models Mech."},{"key":"10.1016\/j.envres.2023.116573_bib200","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75137-y","article-title":"Lipophilic dye-compatible brain clearing technique allowing correlative magnetic resonance\/high-resolution fluorescence imaging in rat models of glioblastoma","volume":"10","author":"Peviani","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib201","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-065X.1999.tb01282.x","article-title":"The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors","volume":"168","author":"Piguet","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.envres.2023.116573_bib202","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR signaling in cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.envres.2023.116573_bib203","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.stem.2018.12.009","article-title":"Cancer stem cells: the architects of the tumor ecosystem","volume":"24","author":"Prager","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.envres.2023.116573_bib204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41698-021-00233-9","article-title":"GD2 CAR T cells against human glioblastoma","volume":"5","author":"Prapa","year":"2021","journal-title":"npj Precis. Onc"},{"key":"10.1016\/j.envres.2023.116573_bib205","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.3390\/ijms18122574","article-title":"Drug resistance driven by cancer stem cells and their niche","volume":"18","author":"Prieto-Vila","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.envres.2023.116573_bib206","article-title":"The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome","volume":"6","author":"Pyfferoen","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.envres.2023.116573_bib207","article-title":"Myeloid-derived suppressor cells alleviate renal fibrosis progression via regulation of CCL5-CCR5 axis","volume":"12","author":"Qiu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.envres.2023.116573_bib208","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1080\/15548627.2019.1687213","article-title":"Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC\/PKC-EZR (ezrin) pathway","volume":"16","author":"Qureshi-Baig","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.envres.2023.116573_bib209","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.3390\/cancers13163949","article-title":"The pathogenic role of PI3K\/AKT pathway in cancer onset and drug resistance: an updated review","volume":"13","author":"Rascio","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.envres.2023.116573_bib210","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12943-021-01487-4","article-title":"Strategies to overcome the main challenges of the use of CRISPR\/Cas9 as a replacement for cancer therapy","volume":"21","author":"Rasul","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.envres.2023.116573_bib211","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2559.2007.02889.x","article-title":"Triple negative tumours: a critical review","volume":"52","author":"Reis-Filho","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.envres.2023.116573_bib212","doi-asserted-by":"crossref","first-page":"75763","DOI":"10.18632\/oncotarget.12409","article-title":"Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer","volume":"7","author":"Ren","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.envres.2023.116573_bib213","first-page":"573","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer","volume":"4","author":"Rinne","year":"2021","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.envres.2023.116573_bib214","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/jcmm.12810","article-title":"CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies","volume":"20","author":"Romanski","year":"2016","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.envres.2023.116573_bib215","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc9450","article-title":"CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy","volume":"6","author":"Rosenblum","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.envres.2023.116573_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114821","article-title":"Recent progress in NIR-II fluorescence imaging-guided drug delivery for cancer theranostics","volume":"197","author":"Roy","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.envres.2023.116573_bib217","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2016.01.011","article-title":"Precision tumor recognition by T cells with combinatorial antigen-sensing circuits","volume":"164","author":"Roybal","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.envres.2023.116573_bib218","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.cell.2005.09.044","article-title":"Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release","volume":"123","author":"Rubin","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.envres.2023.116573_bib219","first-page":"493","article-title":"Evading the immune response upon in vivo gene therapy with viral vectors","volume":"11","author":"Sack","year":"2009","journal-title":"Curr. Opin. Mol. Therapeut."},{"key":"10.1016\/j.envres.2023.116573_bib220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181012","article-title":"Human adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells","volume":"12","author":"Saha","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.envres.2023.116573_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101364","article-title":"The PI3K\/Akt\/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles","volume":"18","author":"Sanaei","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.envres.2023.116573_bib222","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-4939-7565-5_6","article-title":"Detection of retinoblastoma protein phosphorylation by immunoblot analysis","volume":"1726","author":"Santiago-Cardona","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.envres.2023.116573_bib223","first-page":"1","article-title":"Simultaneous CK2\/TNIK\/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease","volume":"12","author":"Sato","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envres.2023.116573_bib224","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.envres.2023.116573_bib225","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.envres.2023.116573_bib226","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13045-022-01349-6","article-title":"TGF-\u03b2 signaling in the tumor metabolic microenvironment and targeted therapies","volume":"15","author":"Shi","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.envres.2023.116573_bib227","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/s41467-022-29638-1","article-title":"AKT mutant allele-specific activation dictates pharmacologic sensitivities","volume":"13","author":"Shrestha Bhattarai","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envres.2023.116573_bib228","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.omto.2021.01.002","article-title":"Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer","volume":"20","author":"Shu","year":"2021","journal-title":"Molecular Therapy - Oncolytics"},{"key":"10.1016\/j.envres.2023.116573_bib229","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.csbj.2021.04.036","article-title":"CRISPR\/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer","volume":"19","author":"Singh","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.envres.2023.116573_bib230","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/cancers15030703","article-title":"Current state and future challenges for PI3K inhibitors in cancer therapy","volume":"15","author":"Sirico","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.envres.2023.116573_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibtech.2022.06.002","article-title":"CRISPR-based systems for sensitive and rapid on-site COVID-19 diagnostics","author":"Soh","year":"2022","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.envres.2023.116573_bib232","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41420-020-0288-x","article-title":"Protein-coated corrole nanoparticles for the treatment of prostate cancer cells","volume":"6","author":"Soll","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.envres.2023.116573_bib233","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.18632\/oncotarget.13907","article-title":"The role of tumor microenvironment in therapeutic resistance","volume":"8","author":"Son","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.envres.2023.116573_bib234","article-title":"Targeted therapy of breast tumor by PLGA-based nanostructures: the versatile function in doxorubicin delivery","volume":"116455","author":"Sonam Dongsar","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.envres.2023.116573_bib235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00244","article-title":"Role of Tcell receptor affinity in the efficacy and specificity of adoptive Tcell therapies","volume":"4","author":"Stone","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.envres.2023.116573_bib236","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.joca.2020.02.027","article-title":"The PI3K\/AKT\/mTOR signaling pathway in osteoarthritis: a narrative review","volume":"28","author":"Sun","year":"2020","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.envres.2023.116573_bib237","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymthe.2020.09.034","article-title":"Olaparib suppresses MDSC recruitment via SDF1\u03b1\/CXCR4 Axis to improve the anti-tumor efficacy of CAR-T cells on breast cancer in mice","volume":"29","author":"Sun","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.envres.2023.116573_bib238","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2386187","article-title":"Immunotherapy with CAR-modified T cells: toxicities and overcoming strategies","author":"Sun","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.envres.2023.116573_bib239","series-title":"Abeloff's Clinical Oncology","first-page":"470","article-title":"29 - gene therapy in oncology","author":"Talmadge","year":"2020"},{"key":"10.1016\/j.envres.2023.116573_bib240","doi-asserted-by":"crossref","DOI":"10.1038\/s41592-019-0642-1","article-title":"Exploring class 1 CRISPR systems","volume":"16","author":"Tang","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.envres.2023.116573_bib241","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13578-018-0255-x","article-title":"Class 2 CRISPR\/Cas: an expanding biotechnology toolbox for and beyond genome editing","volume":"8","author":"Tang","year":"2018","journal-title":"Cell Biosci."},{"key":"10.1016\/j.envres.2023.116573_bib242","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1182\/blood.2020008017","article-title":"Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition","volume":"137","author":"Tannan","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.envres.2023.116573_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215697","article-title":"Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer","volume":"538","author":"Taromi","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.envres.2023.116573_bib244","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/cgt.2011.66","article-title":"Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor","volume":"19","author":"Tassev","year":"2012","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.envres.2023.116573_bib245","doi-asserted-by":"crossref","first-page":"31876","DOI":"10.18632\/oncotarget.16311","article-title":"Tumor hypoxia modulates podoplanin\/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization","volume":"8","author":"Tejchman","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.envres.2023.116573_bib246","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/diagnostics13040766","article-title":"Molecular diagnosis and cancer prognosis\u2014a concise review","volume":"13","author":"Thenrajan","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.envres.2023.116573_bib247","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71091-x","article-title":"A novel epitope tagging system to visualize and monitor antigens in live cells with chromobodies","volume":"10","author":"Traenkle","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib248","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.638841","article-title":"Interaction between MDSC and NK cells in solid and hematological malignancies: impact on HSCT","volume":"12","author":"Tumino","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.envres.2023.116573_bib249","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1080\/01635581.2021.1952628","article-title":"Quercetin impairs HuR-driven progression and migration of triple negative breast cancer (TNBC) cells","volume":"74","author":"Umar","year":"2022","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.envres.2023.116573_bib250","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.gendis.2020.09.002","article-title":"Cancer: an unknown territory; rethinking before going ahead","volume":"8","author":"Upadhyay","year":"2020","journal-title":"Genes Dis"},{"key":"10.1016\/j.envres.2023.116573_bib251","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2018.12.031","article-title":"Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer","volume":"294","author":"Uz","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.envres.2023.116573_bib252","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.imlet.2019.03.004","article-title":"Interactions between cancer stem cells, immune system and some environmental components: friends or foes?","volume":"208","author":"Vahidian","year":"2019","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.envres.2023.116573_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120217","article-title":"Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells","volume":"597","author":"Valsalakumari","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.envres.2023.116573_bib254","first-page":"1","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.envres.2023.116573_bib255","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.3390\/ijms18081776","article-title":"The retinoblastoma (RB) tumor suppressor: pushing back against genome instability on multiple fronts","volume":"18","author":"V\u00e9lez-Cruz","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.envres.2023.116573_bib256","first-page":"201","article-title":"The landscape of PIK3CA mutations in colorectal cancer","volume":"20","author":"Voutsadakis","year":"2021","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.envres.2023.116573_bib257","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.ymthe.2020.09.015","article-title":"CAR T cell therapy for solid tumors: bright future or dark reality?","volume":"28","author":"Wagner","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.envres.2023.116573_bib258","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01280","article-title":"Cancer stem cells\u2014origins and biomarkers: perspectives for targeted personalized therapies","volume":"11","author":"Walcher","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.envres.2023.116573_bib259","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.ymthe.2021.04.015","article-title":"Beyond cancer cells: targeting the tumor microenvironment with gene therapy and armed oncolytic virus","volume":"29","author":"Wan","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.envres.2023.116573_bib260","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13046-020-01820-7","article-title":"Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy","volume":"40","author":"Wang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.envres.2023.116573_bib261","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6584","article-title":"Engineering nanoparticles to locally activate T cells in the tumor microenvironment","volume":"4","author":"Wang","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.envres.2023.116573_bib262","article-title":"Depletion-assisted multiplexing cell-free RNA sequencing reveals distinct human and microbial signatures in plasma versus extracellular vesicle","author":"Wang","year":"2023","journal-title":"stl"},{"key":"10.1016\/j.envres.2023.116573_bib263","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41392-020-00248-x","article-title":"Nanoparticle enhanced combination therapy for stem-like progenitors defined by single-cell transcriptomics in chemotherapy-resistant osteosarcoma","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.envres.2023.116573_bib264","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.1007\/s11033-022-07519-6","article-title":"Recent advances of the biological and biomedical applications of CRISPR\/Cas systems","volume":"49","author":"Wang","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib265","article-title":"Granulocytic myeloid\u2010derived suppressor cells promote the stemness of colorectal cancer cells through exosomal S100A9","volume":"6","author":"Wang","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.envres.2023.116573_bib266","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.4161\/cbt.29842","article-title":"Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cells","volume":"15","author":"Wei","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.envres.2023.116573_bib267","first-page":"1271","article-title":"Hypoxia enhances immunosuppression by inhibiting CD4+ effector T cell function and promoting Treg activity","volume":"41","author":"Westendorf","year":"2017","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.envres.2023.116573_bib268","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.4161\/cc.11.6.19530","article-title":"Using the \u201creverse Warburg effect\u201d to identify high-risk breast cancer patients","volume":"11","author":"Witkiewicz","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.envres.2023.116573_bib269","series-title":"Gene Therapy of Cancer","first-page":"53","article-title":"Chapter 3 - parvovirus vectors for the gene therapy of cancer","author":"Wong","year":"2002"},{"key":"10.1016\/j.envres.2023.116573_bib270","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.xphs.2021.01.018","article-title":"Liposomal thiostrepton formulation and its effect on breast cancer growth inhibition","volume":"110","author":"Wongkhieo","year":"2021","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.envres.2023.116573_bib271","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s13046-019-1310-0","article-title":"IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma","volume":"38","author":"Wu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.envres.2023.116573_bib272","doi-asserted-by":"crossref","DOI":"10.1063\/5.0073746","article-title":"Engineering CAR T cells for enhanced efficacy and safety","volume":"6","author":"Wu","year":"2022","journal-title":"APL Bioeng"},{"key":"10.1016\/j.envres.2023.116573_bib273","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100833","article-title":"The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells","volume":"62","author":"Xavier","year":"2022","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.envres.2023.116573_bib274","first-page":"1602","article-title":"PI3K\/Akt\/mTOR signaling pathway in cancer stem cells: from basic research to clinical application","volume":"5","author":"Xia","year":"2015","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.envres.2023.116573_bib275","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1038\/s41467-021-23466-5","article-title":"Systemic metastasis-targeted nanotherapeutic reinforces tumor surgical resection and chemotherapy","volume":"12","author":"Xu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envres.2023.116573_bib276","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113891","article-title":"Nanotechnology-based delivery of CRISPR\/Cas9 for cancer treatment","volume":"176","author":"Xu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.envres.2023.116573_bib277","doi-asserted-by":"crossref","first-page":"944","DOI":"10.54097\/hset.v36i.6133","article-title":"Limitations and overcomes of CAR-NK for cancer immunotherapy","volume":"36","author":"Xue","year":"2023","journal-title":"HSET"},{"key":"10.1016\/j.envres.2023.116573_bib278","first-page":"954","article-title":"Oncolytic potential of an E4-deficient adenovirus that can recognize the stabilization of AU-rich element containing mRNA in cancer cells","volume":"41","author":"Yanagawa-Matsuda","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib279","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1038\/s41467-021-23710-y","article-title":"Intratumoral synthesis of nano-metalchelate for tumor catalytic therapy by ligand field-enhanced coordination","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envres.2023.116573_bib280","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.envres.2023.116573_bib281","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1111\/j.1365-2567.2008.02954.x","article-title":"Hypoxia skews dendritic cells to a T helper type 2-stimulating phenotype and promotes tumour cell migration by dendritic cell-derived osteopontin","volume":"128","author":"Yang","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.envres.2023.116573_bib282","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1189\/jlb.0910506","article-title":"Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer","volume":"89","author":"Yang","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.envres.2023.116573_bib283","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/0008-5472.CAN-15-0977","article-title":"Hypoxia-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma induces an immunosuppressive tumor microenvironment to promote metastasis","volume":"76","author":"Ye","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.envres.2023.116573_bib284","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.hemonc.2021.02.002","article-title":"Molecular mediators of breast cancer metastasis","volume":"14","author":"Yeeravalli","year":"2021","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.envres.2023.116573_bib285","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1038\/s41467-019-11718-4","article-title":"Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy","volume":"10","author":"Yong","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envres.2023.116573_bib286","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41389-020-00300-z","article-title":"PI3K\/Akt pathway and Nanog maintain cancer stem cells in sarcomas","volume":"10","author":"Yoon","year":"2021","journal-title":"Oncogenesis"},{"key":"10.1016\/j.envres.2023.116573_bib287","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91352-7","article-title":"Facile fabricating of rGO and Au\/rGO nanocomposites using Brassica oleracea var. gongylodes biomass for non-invasive approach in cancer therapy","volume":"11","author":"Yousefimehr","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib288","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ymthe.2017.12.012","article-title":"Development of GPC3-specific chimeric antigen receptor-engineered natural killer cells for the treatment of hepatocellular carcinoma","volume":"26","author":"Yu","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.envres.2023.116573_bib289","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12943-019-1057-4","article-title":"Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity","volume":"18","author":"Yu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.envres.2023.116573_bib290","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nnano.2016.168","article-title":"Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues","volume":"11","author":"Zanganeh","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.envres.2023.116573_bib291","doi-asserted-by":"crossref","first-page":"djv375","DOI":"10.1093\/jnci\/djv375","article-title":"ErbB2\/HER2-Specific NK cells for targeted therapy of glioblastoma","volume":"108","author":"Zhang","year":"2016","journal-title":"J. Natl. Cancer Inst.: J. Natl. Cancer Inst."},{"key":"10.1016\/j.envres.2023.116573_bib292","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-016-0379-6","article-title":"A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy","volume":"10","author":"Zhang","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.envres.2023.116573_bib293","doi-asserted-by":"crossref","first-page":"E6215","DOI":"10.1073\/pnas.1520032112","article-title":"HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells","volume":"112","author":"Zhang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.envres.2023.116573_bib294","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.apsb.2020.10.022","article-title":"Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.envres.2023.116573_bib295","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41565-019-0626-4","article-title":"Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo","volume":"15","author":"Zhang","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"17","key":"10.1016\/j.envres.2023.116573_bib296","article-title":"Role of hypoxia inducible factor-1 in cancer stem cells (Review)","volume":"23","author":"Zhang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib297","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jconrel.2020.08.023","article-title":"DP7-C-modified liposomes enhance immune responses and the antitumor effect of a neoantigen-based mRNA vaccine","volume":"328","author":"Zhang","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.envres.2023.116573_bib298","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41467-021-21618-1","article-title":"Photocatalysis-mediated drug-free sustainable cancer therapy using nanocatalyst","volume":"12","author":"Zhao","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envres.2023.116573_bib299","article-title":"Oncolytic adenovirus: prospects for cancer immunotherapy","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.envres.2023.116573_bib300","article-title":"Targeted delivery of doxorubicin by nano-loaded mesenchymal stem cells for lung melanoma metastases therapy","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib301","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.21037\/jtd.2020.03.118","article-title":"CAR-T cell therapy for lung cancer: a promising but challenging future","volume":"12","author":"Zhong","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.envres.2023.116573_bib302","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-020-00430-1","article-title":"Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.envres.2023.116573_bib303","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1111\/jcmm.13925","article-title":"The applications of CRISPR\/Cas system in molecular detection","volume":"22","author":"Zhou","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.envres.2023.116573_bib304","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/bit.27334","article-title":"Novel nucleic acid detection strategies based on CRISPR-Cas systems: from construction to application","volume":"117","author":"Zhu","year":"2020","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.envres.2023.116573_bib305","article-title":"Synergistic effect of cold atmospheric plasma and drug loaded core-shell nanoparticles on inhibiting breast cancer cell growth","volume":"6","author":"Zhu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116573_bib306","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz6108","article-title":"Targeted gene silencing in vivo by platelet membrane\u2013coated metal-organic framework nanoparticles","volume":"6","author":"Zhuang","year":"2020","journal-title":"Sci. Adv."}],"container-title":["Environmental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013935123013774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013935123013774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:36:49Z","timestamp":1789677409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013935123013774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":306,"alternative-id":["S0013935123013774"],"URL":"https:\/\/doi.org\/10.1016\/j.envres.2023.116573","relation":{},"ISSN":["0013-9351"],"issn-type":[{"value":"0013-9351","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells mediated therapeutics","name":"articletitle","label":"Article Title"},{"value":"Environmental Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.envres.2023.116573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116573"}}